Identification of novel candidate biomarkers for heart failure with preserved ejection fraction by the Olink proteomics platform [0.03%]
通过Olink蛋白组学平台鉴定新型射血分数保留的心力衰竭生物标志物候选人
Huang Yimei,Chen Xinyun,Hu Yuchi et al.
Huang Yimei et al.
Background: The pathophysiology of heart failure with preserved ejection fraction (HFpEF) remains incompletely understood. Objective: T...
Syndecan-1, endocan and non-culprit coronary plaque composition following non-ST elevation myocardial infarction [0.03%]
NSTE心梗后非罪犯冠脉斑块组成与Syndecan-1和Endocan的关系
Naomi E Wattchow,Thalia Salagaras,Mau T Nguyen et al.
Naomi E Wattchow et al.
Background: Syndecan-1 and endocan are biomarkers of endothelial damage, which associate with worse outcomes after myocardial infarction (MI). As it is unclear how this is mediated, we investigated how they associate with...
ECG and imaging manifestations of cardiomyopathy in adults with Duchenne muscular dystrophy [0.03%]
杜氏肌营养不良成人患者心肌病的心电图及影像学表现
Peter C Murray,Ailis Pollock,Katie Hewitt et al.
Peter C Murray et al.
Background / aims: Cardiomyopathy is universally penetrant in young adults with Duchenne muscular dystrophy (DMD), and is increasingly the preponderant cause of death. We describe the ECG, echocardiography and cardiac MRI...
Oral P2Y12 inhibitors only versus cangrelor in critically ill patients requiring percutaneous coronary interventions supported by microaxial flow pumps [0.03%]
口服P2Y12抑制剂与坎格雷洛在依赖微型轴流泵的支持下接受经皮冠状动脉介入治疗的危重患者中的对比研究
Chiara Schaffner,Yanick Spahr,Alessandro Spirito et al.
Chiara Schaffner et al.
Background: Oral P2Y12 inhibitors (P2Y12i) may have reduced efficacy in critically ill patients undergoing Impella-supported PCI. The intravenous P2Y12i cangrelor offers rapid and reversible platelet inhibition, but its r...
One-year worsening heart failure and myocardial T1 mapping in patients with wild-type transthyretin amyloid cardiomyopathy undergoing tafamidis treatment [0.03%]
接受塔法莫迪斯治疗的野生型甲状腺素转运蛋白心肌病患者一年内心脏衰竭恶化和心肌T1图变化
Toshiro Kitagawa,Kotaro Hamamoto,Daiki Okamoto et al.
Toshiro Kitagawa et al.
Background: There is a paucity of data regarding short-term outcomes and treatment responsiveness of myocardial T1 mapping via cardiac magnetic resonance (CMR) in patients with transthyretin amyloid cardiomyopathy (ATTR-C...
Peak aortic jet velocity as a predictor of short- and long-term outcomes following percutaneous coronary intervention [0.03%]
经皮冠状动脉介入治疗术后主动脉喷射速度峰值对短期和长期预后的预测价值
Takamasa Iwai,Kensuke Takagi,Takeshi Kitai et al.
Takamasa Iwai et al.
Background: Coronary artery disease (CAD) and aortic valve stenosis (AS) often coexist, with AS exacerbating myocardial ischemia and affecting prognosis. ...
Revisiting outcomes after transcatheter aortic valve replacement: The need for a multidimensional approach to patient management [0.03%]
经导管主动脉瓣置换术后结果的再评价：患者管理多维度方法的需求
Carmelita Cieri,Michele Russo,Marco Zimarino
Carmelita Cieri
Cardiac dysfunction after acute ischaemic stroke: Long-term outcomes from the SICFAIL cohort [0.03%]
急性缺血性卒中后的心脏功能障碍：来自SICFAIL队列的长期结果分析
Kathrin Ungethüm,Felipe A Montellano,Viktoria Rücker et al.
Kathrin Ungethüm et al.
Background: Systolic dysfunction, diastolic dysfunction, and clinically overt heart failure are frequently encountered after acute ischaemic stroke. We investigated whether these cardiac phenotypes, considered as distinct...
Risk prediction of atrial fibrillation progression in patients with paroxysmal atrial fibrillation: data from the RACE V study [0.03%]
阵发性房颤患者向持续性房颤进展的风险预测：来自RACE V研究的数据
D K Baron,M Samuel,H J G M Crijns et al.
D K Baron et al.
Background: Atrial Fibrillation (AF) may progress from paroxysmal AF (PAF) to more sustained forms, but predicting which patients progress remains a challenge. The RACE V study is a prospective, observational study aiming...
Persistent left superior vena cava is associated with complex atrial tachyarrhythmias in repaired tetralogy of Fallot: evidence for a right-sided arrhythmogenic substrate [0.03%]
持续存在的左侧上腔静脉与修复后的法洛四联症的复杂房性快速心律失常相关：右侧心律失常发病机制的证据
Tabito Kino,Miyako Igarashi,Yuta Suto et al.
Tabito Kino et al.
Background: Atrial fibrillation (AF) is an important late complication in patients with repaired tetralogy of Fallot (TOF); however, its clinical determinants and arrhythmogenic substrates remain uncertain. Identifying hi...